Saxenda is a prescription injection used for long-term weight management in adults with obesity or in adults with overweight who also have at least one weight-related health condition, such as high blood pressure or high cholesterol. It’s also approved for adolescents aged 12 and older who have obesity. Saxenda is not a standalone treatment. It’s meant to be used alongside a reduced-calorie diet and increased physical activity.
Who Qualifies for Saxenda
The FDA approval covers two groups of adults. The first is people with obesity, defined as a BMI of 30 or higher. The second is people with a BMI between 27 and 29.9 (the “overweight” range) who also have at least one weight-related comorbidity like high blood pressure, high cholesterol, or type 2 diabetes. You don’t qualify based on BMI alone if you fall in that lower range; the additional health condition is required.
For adolescents aged 12 and older, the criteria are different. They must weigh more than 60 kg (about 132 pounds) and meet the clinical definition of obesity for their age and sex, which means a BMI at or above the 95th percentile. The FDA approved Saxenda for this age group in December 2020.
How Saxenda Works in Your Body
Saxenda’s active ingredient, liraglutide, is a GLP-1 receptor agonist. Your gut naturally produces a hormone called GLP-1 after you eat, but the body breaks it down within minutes. Liraglutide mimics that hormone and sticks around much longer, which amplifies its effects.
The weight loss comes from multiple directions. In the brain, liraglutide acts on regions that control hunger and fullness, suppressing appetite and making you feel satisfied sooner during meals. In the digestive system, it slows gastric emptying, meaning food stays in your stomach longer, which extends that feeling of fullness after eating. The net result is that you naturally consume fewer calories without the same level of hunger you’d feel on a diet alone. Liraglutide also helps regulate blood sugar by boosting insulin release and reducing glucagon (a hormone that raises blood sugar), which provides metabolic benefits beyond just the number on the scale.
How Much Weight People Typically Lose
In the largest clinical trial, which enrolled over 3,700 patients, 63% of people taking Saxenda lost at least 5% of their body weight, compared with 27% on placebo. About a third of Saxenda users lost more than 10% of their body weight, versus 10% in the placebo group. For someone starting at 220 pounds, 5% is 11 pounds and 10% is 22 pounds.
These numbers represent averages across a large study population, and individual results vary. The medication works best when paired with real changes to eating and activity habits. If it’s not producing meaningful results after several months at the full dose, your prescriber will likely reassess whether it’s worth continuing.
Dosing and What to Expect
Saxenda is a once-daily injection you give yourself using a prefilled pen. You inject it under the skin in your abdomen, thigh, or upper arm. The dose ramps up gradually over five weeks to reduce side effects, especially nausea:
- Week 1: 0.6 mg daily
- Week 2: 1.2 mg daily
- Week 3: 1.8 mg daily
- Week 4: 2.4 mg daily
- Week 5 onward: 3 mg daily (maintenance dose)
The full 3 mg dose is where the clinical benefit kicks in. The earlier weeks are about letting your body adjust. Nausea is the most common side effect during the ramp-up period and often fades as your body acclimates. You can take Saxenda at any time of day, with or without food, though picking a consistent time helps build the habit.
Important Safety Considerations
Saxenda carries a boxed warning (the most serious type of FDA warning) related to thyroid tumors. In animal studies, liraglutide caused thyroid C-cell tumors in rodents. It’s not confirmed whether this risk extends to humans, but as a precaution, Saxenda is contraindicated in anyone with a personal or family history of medullary thyroid carcinoma or a rare condition called Multiple Endocrine Neoplasia syndrome type 2.
The most common side effects are gastrointestinal: nausea, diarrhea, constipation, and vomiting. These tend to be worst during the dose escalation phase and improve over time. More serious but less common risks include inflammation of the pancreas (pancreatitis), gallbladder problems, and increased heart rate. If you experience severe, persistent abdominal pain, that warrants prompt medical attention.
How Saxenda Compares to Similar Medications
Saxenda belongs to the same drug class as newer, higher-profile weight loss medications like semaglutide (sold as Wegovy for weight management). Both are GLP-1 receptor agonists, but they differ in dosing frequency and effectiveness. Semaglutide is a once-weekly injection and has shown larger average weight loss in head-to-head comparisons. Saxenda requires daily injections, which some people find less convenient.
It’s also worth knowing that liraglutide is the same molecule used in Victoza, a diabetes medication, but at a lower dose. Saxenda and Victoza should never be used together, and Saxenda is not approved as a diabetes treatment, even though it does affect blood sugar regulation.